LEXX
Lexaria Bioscience Corp
NASDAQ · Pharmaceuticals
$0.73
+0.06 (+9.52%)
Open$0.67
Previous Close$0.66
Day High$0.79
Day Low$0.67
52W High$29.95
52W Low$17.61
Volume—
Avg Volume447.5K
Market Cap18.04M
P/E Ratio—
EPS$-1.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,545.5% upside
Current
$0.73
$0.73
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.40M | 9.47M | 8.19M |
| Net Income | 2.29M | 1.90M | 1.93M |
| Profit Margin | 24.3% | 20.1% | 23.6% |
| EBITDA | 3.25M | 3.60M | 2.84M |
| Free Cash Flow | 1.64M | 1.11M | 1.29M |
| Rev Growth | +24.3% | +1.1% | -8.2% |
| Debt/Equity | 0.98 | 0.74 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |